GlassScriptPhysician profile
Michael R Clopp
NPI 1285749507
$768.23
in general payments reported to CMS, 2019-2025
11 companies · $11.32 in 2025
The $11.32 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.92 · 2020: $75.00 · 2021: $334 · 2022: $45.69 · 2023: $12.79 · 2024: $205 · 2025: $11.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $273.38 | 2021 | |
| Dentsply Sirona INC | $205.25 | 2024 | Primescan Connect, Suresmile |
| Zimmer Biomet Holdings, INC. | $140.57 | 2019-2020 | |
| Kulzer, LLC | $46.20 | 2021 | |
| Kavo Dental Technologies LLC | $18.35 | 2019 | |
| Kerr Corporation | $17.77 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $14.68 | 2021 | |
| Implant Direct Sybron International LLC | $14.02 | 2022 | |
| Zimvie INC. | $13.90 | 2022 | |
| Straumann USA LLC | $12.79 | 2023 | |
| Voco America INC. | $11.32 | 2025 | Ufi Gel Hard C, Structur 3, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.